Article
A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection
3 Oct 2024
Abstract excerpt
Clostridioides difficile infection (CDI) is an urgent public health threat with limited preventative options. In this work, we developed a messenger RNA (mRNA)–lipid nanoparticle (LNP) vaccine targeting C. difficile toxins and virulence factors. This multivalent vaccine elicited robust and long-lived systemic and mucosal antigen-specific humoral and cellular immune responses across animal models, independent of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
